,address1,address2,city,state,zip,country,phone,fax,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,11555 Sorrento Valley Road,Suite 203,San Diego,CA,92121,United States,619 941 0360,619 941 0361,https://www.aethlonmedical.com,Medical Devices,Medical Devices,Healthcare,Healthcare,"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.",15,"{'maxAge': 1, 'name': 'Dr. Charles J. Fisher Jr., M.D.', 'age': 75, 'title': 'CEO, Director & Member of Extracorporeal Therapy Advisory Board', 'yearBorn': 1947, 'fiscalYear': 2023, 'totalPay': 460000, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.274,0.264,0.2538,0.27,0.274,0.264,0.2538,0.27,0.0,1.307053,-0.38571432,126679,126679,293538,96270,96270,0.258,0.269,4000,3200,6705531,0.23,0.93,11.677126,0.3358,0.3878,0.0,0.0,USD,-5047732,0.0,24487130,24835300,104400,177140,1690761600,1693440000,0.0042,0.03063,0.04397,0.84,0.0043,24835300,0.528,0.5113637,1680220800,1711843200,1688083200,-12406297,-0.58,-0.7,1:15,1571097600,-8.79,0.417,-0.6966292,0.14113986,NCM,EQUITY,AEMD,AEMD,"Aethlon Medical, Inc.","Aethlon Medical, Inc.",920557800,America/New_York,EDT,66b9f885-0b09-302d-b962-5780d51313cc,finmb_683712,-14400000,0.27,9.0,4.0,6.5,6.5,3.0,hold,2,12897734,0.519,-12100150,1144465,7.08,7.305,574245,8.73,0.025,-0.47068,-0.88521004,574245,-6894458,-10258598,1.0,0.0,-21.59482,USD,
1,11555 Sorrento Valley Road,Suite 203,San Diego,CA,92121,United States,619 941 0360,619 941 0361,https://www.aethlonmedical.com,Medical Devices,Medical Devices,Healthcare,Healthcare,"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.",15,"{'maxAge': 1, 'name': 'Mr. Guy F. Cipriani BS (Eng.), MBA', 'age': 52, 'title': 'Sr. VP, Chief Bus. Officer & Director', 'yearBorn': 1970, 'fiscalYear': 2023, 'totalPay': 347500, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.274,0.264,0.2538,0.27,0.274,0.264,0.2538,0.27,0.0,1.307053,-0.38571432,126679,126679,293538,96270,96270,0.258,0.269,4000,3200,6705531,0.23,0.93,11.677126,0.3358,0.3878,0.0,0.0,USD,-5047732,0.0,24487130,24835300,104400,177140,1690761600,1693440000,0.0042,0.03063,0.04397,0.84,0.0043,24835300,0.528,0.5113637,1680220800,1711843200,1688083200,-12406297,-0.58,-0.7,1:15,1571097600,-8.79,0.417,-0.6966292,0.14113986,NCM,EQUITY,AEMD,AEMD,"Aethlon Medical, Inc.","Aethlon Medical, Inc.",920557800,America/New_York,EDT,66b9f885-0b09-302d-b962-5780d51313cc,finmb_683712,-14400000,0.27,9.0,4.0,6.5,6.5,3.0,hold,2,12897734,0.519,-12100150,1144465,7.08,7.305,574245,8.73,0.025,-0.47068,-0.88521004,574245,-6894458,-10258598,1.0,0.0,-21.59482,USD,
2,11555 Sorrento Valley Road,Suite 203,San Diego,CA,92121,United States,619 941 0360,619 941 0361,https://www.aethlonmedical.com,Medical Devices,Medical Devices,Healthcare,Healthcare,"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.",15,"{'maxAge': 1, 'name': 'Dr. Steven P. LaRosa M.D.', 'age': 55, 'title': 'Chief Medical Officer', 'yearBorn': 1967, 'fiscalYear': 2023, 'totalPay': 430000, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.274,0.264,0.2538,0.27,0.274,0.264,0.2538,0.27,0.0,1.307053,-0.38571432,126679,126679,293538,96270,96270,0.258,0.269,4000,3200,6705531,0.23,0.93,11.677126,0.3358,0.3878,0.0,0.0,USD,-5047732,0.0,24487130,24835300,104400,177140,1690761600,1693440000,0.0042,0.03063,0.04397,0.84,0.0043,24835300,0.528,0.5113637,1680220800,1711843200,1688083200,-12406297,-0.58,-0.7,1:15,1571097600,-8.79,0.417,-0.6966292,0.14113986,NCM,EQUITY,AEMD,AEMD,"Aethlon Medical, Inc.","Aethlon Medical, Inc.",920557800,America/New_York,EDT,66b9f885-0b09-302d-b962-5780d51313cc,finmb_683712,-14400000,0.27,9.0,4.0,6.5,6.5,3.0,hold,2,12897734,0.519,-12100150,1144465,7.08,7.305,574245,8.73,0.025,-0.47068,-0.88521004,574245,-6894458,-10258598,1.0,0.0,-21.59482,USD,
3,11555 Sorrento Valley Road,Suite 203,San Diego,CA,92121,United States,619 941 0360,619 941 0361,https://www.aethlonmedical.com,Medical Devices,Medical Devices,Healthcare,Healthcare,"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.",15,"{'maxAge': 1, 'name': 'Mr. James B. Frakes M.B.A.', 'age': 65, 'title': 'CFO, Sr. VP of Fin. & Sec.', 'yearBorn': 1957, 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.274,0.264,0.2538,0.27,0.274,0.264,0.2538,0.27,0.0,1.307053,-0.38571432,126679,126679,293538,96270,96270,0.258,0.269,4000,3200,6705531,0.23,0.93,11.677126,0.3358,0.3878,0.0,0.0,USD,-5047732,0.0,24487130,24835300,104400,177140,1690761600,1693440000,0.0042,0.03063,0.04397,0.84,0.0043,24835300,0.528,0.5113637,1680220800,1711843200,1688083200,-12406297,-0.58,-0.7,1:15,1571097600,-8.79,0.417,-0.6966292,0.14113986,NCM,EQUITY,AEMD,AEMD,"Aethlon Medical, Inc.","Aethlon Medical, Inc.",920557800,America/New_York,EDT,66b9f885-0b09-302d-b962-5780d51313cc,finmb_683712,-14400000,0.27,9.0,4.0,6.5,6.5,3.0,hold,2,12897734,0.519,-12100150,1144465,7.08,7.305,574245,8.73,0.025,-0.47068,-0.88521004,574245,-6894458,-10258598,1.0,0.0,-21.59482,USD,
4,11555 Sorrento Valley Road,Suite 203,San Diego,CA,92121,United States,619 941 0360,619 941 0361,https://www.aethlonmedical.com,Medical Devices,Medical Devices,Healthcare,Healthcare,"Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.",15,"{'maxAge': 1, 'name': 'Dr. Lee D. Arnold Ph.D.', 'age': 62, 'title': 'Chief Scientific Officer', 'yearBorn': 1960, 'exercisedValue': 0, 'unexercisedValue': 0}",1703980800,86400,4,0.274,0.264,0.2538,0.27,0.274,0.264,0.2538,0.27,0.0,1.307053,-0.38571432,126679,126679,293538,96270,96270,0.258,0.269,4000,3200,6705531,0.23,0.93,11.677126,0.3358,0.3878,0.0,0.0,USD,-5047732,0.0,24487130,24835300,104400,177140,1690761600,1693440000,0.0042,0.03063,0.04397,0.84,0.0043,24835300,0.528,0.5113637,1680220800,1711843200,1688083200,-12406297,-0.58,-0.7,1:15,1571097600,-8.79,0.417,-0.6966292,0.14113986,NCM,EQUITY,AEMD,AEMD,"Aethlon Medical, Inc.","Aethlon Medical, Inc.",920557800,America/New_York,EDT,66b9f885-0b09-302d-b962-5780d51313cc,finmb_683712,-14400000,0.27,9.0,4.0,6.5,6.5,3.0,hold,2,12897734,0.519,-12100150,1144465,7.08,7.305,574245,8.73,0.025,-0.47068,-0.88521004,574245,-6894458,-10258598,1.0,0.0,-21.59482,USD,
